Dividend Assets Capital’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.26M Buy
65,261
+6,168
+10% +$632K 1.21% 29
2026
Q1
$6.45M Sell
59,093
-13,093
-18% -$1.25M 1.29% 29
2025
Q4
$5.85M Buy
72,186
+2,862
+4% +$246K 1.12% 33
2025
Q3
$6.07M Buy
69,324
+14,663
+27% +$1.31M 1.06% 33
2025
Q2
$4.54M Buy
54,661
+8,453
+18% +$706K 0.82% 42
2025
Q1
$3.88M Buy
+46,208
New +$4.3M 0.73% 41

Other funds holding LMAT

Dividend Assets Capital's LMAT Position: Q2 2026 in Review

Dividend Assets Capital increased its LeMaitre Vascular (LMAT) stake by 10% in Q2 2026, buying an estimated $632K and bringing the position to 65,261 shares worth $6.26M. The position accounts for 1.21% of the portfolio, ranked #29.

Dividend Assets Capital first reported a position in LMAT in Q1 2025 and has held it in 6 quarters since. The position peaked at $6.45M in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Dividend Assets Capital held 65,261 shares of LeMaitre Vascular worth $6.26M as of Q2 2026.
  • Dividend Assets Capital bought 6,168 LeMaitre Vascular shares in Q2 2026, an estimated $632K.
  • LeMaitre Vascular made up 1.21% of Dividend Assets Capital's portfolio in Q2 2026, its #29 holding.
  • Dividend Assets Capital first reported a position in LeMaitre Vascular in Q1 2025 and has held it in 6 quarters since.
  • Dividend Assets Capital's LeMaitre Vascular position peaked at $6.45M in Q1 2026.
  • 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Dividend Assets Capital's 13F filing for Q2 2026, filed 12 Aug 2026.